Invuity, which sells illumination devices used in minimally invasive and minimal access surgeries, raised $48 million by offering 4 million shares at $12, as expected. The company had originally planned a price range of $14-$16 before lowering the IPO range on Thursday. Invuity plans to list on the NASDAQ under the symbol IVTY. Piper Jaffray, Leerink Partners and Stifel acted as lead managers on the deal.
